
Cefipark T 1000mg/125mg Injection
Marketer
Park Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefipark T 1000mg/125mg Injection
Combiflox Injection (Cefipark T equivalent, 1000mg/125mg) is a dual-action antibiotic indicated for diverse bacterial infections. It combats microorganisms, inhibiting their proliferation and infection spread. Administration must be solely under medical guidance. Complete all prescribed doses; premature cessation may reduce efficacy. Regularly scheduled appointments are crucial. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek urgent medical attention for allergic responses (rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Cefipark T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefipark T 1000mg/125mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefipark T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefipark T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefipark T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam (Cefipark T 1000mg/125mg Injection) is a dual-action antibiotic. Ceftriaxone, a cephalosporin, inhibits bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Cefipark T 1000mg/125mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefipark T (1000mg/125mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are currently insufficient.
Breast feedingCAUTION
Administering Cefipark T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Nursing mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administering Cefipark T 1000mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefipark T 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cefipark T 1000mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration for Cefipark T 1000mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefipark T 1000mg/125mg Injection :
Omit a Cefipark T 1000mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Cefipark T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
